Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Shares Issued (2016 - 2025)

IGC Pharma (IGC) has disclosed Shares Issued for 15 consecutive years, with $3.1 million as the latest value for Q3 2025.

  • Quarterly Shares Issued rose 291.32% to $3.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Sep 2025, up 47.38% year-over-year, with the annual reading at $4.5 million for FY2025, 47.14% up from the prior year.
  • Shares Issued for Q3 2025 was $3.1 million at IGC Pharma, up from $852000.0 in the prior quarter.
  • The five-year high for Shares Issued was $14.2 million in Q1 2021, with the low at -$103000.0 in Q1 2023.
  • Average Shares Issued over 5 years is $2.3 million, with a median of $805000.0 recorded in 2025.
  • The sharpest move saw Shares Issued skyrocketed 78755.56% in 2021, then plummeted 96.99% in 2022.
  • Over 5 years, Shares Issued stood at $3.4 million in 2021, then tumbled by 96.99% to $103000.0 in 2022, then soared by 2676.7% to $2.9 million in 2023, then crashed by 87.9% to $346000.0 in 2024, then soared by 799.13% to $3.1 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $3.1 million, $852000.0, and $805000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.